speb/financial-data huggingface dataset:
DuPont ROE decomposition for CRI (annual period ending 2023-12-31)
ROE: 28.32500537565962%
Net margin: 7.893144812217841%
Asset turnover: 1.2226623011135813
Equity multiplier (leverage): 2.935035838746049
EBIT margin: 10.979279561270154%
Interest burden factor: 0.9345619269955628
Tax burden factor: 0.769251129889294
ROE archetype: Leverage-Driven Returns
DuPont ROE decomposition for CRI (annual period ending 2024-12-31)
ROE: 21.82700204493203%
Net margin: 6.522586039459907%
Asset turnover: 1.1821413281571476
Equity multiplier (leverage): 2.830771873595433
EBIT margin: 10.011174001495023%
Interest burden factor: 0.8106297940490573
Tax burden factor: 0.8037338232044677
ROE archetype: Leverage-Driven Returns
DuPont ROE decomposition for CRI (annual period ending 2025-12-31)
ROE: 10.316417642067643%
Net margin: 3.167098280238999%
Asset turnover: 1.1596865305482273
Equity multiplier (leverage): 2.8088384533689967
EBIT margin: 4.965902182770924%
Interest burden factor: 0.7908818686472178
Tax burden factor: 0.806402305110951
ROE archetype: Standard Business
DuPont ROE decomposition for CRIN.DE (quarterly period ending 2024-12-31)
ROE: 3.1874094938018174%
Net margin: 33.294547872340424%
Asset turnover: 0.007673430237600829
Equity multiplier (leverage): 12.475994971435847
Tax burden factor: 0.9965174129353235
ROE archetype: Low Return
DuPont ROE decomposition for CRIN.DE (quarterly period ending 2025-03-31)
ROE: 4.4277763615858685%
Net margin: 42.569423252975284%
Asset turnover: 0.008471875083145517
Equity multiplier (leverage): 12.27745547013219
Tax burden factor: 0.713007922310248
ROE archetype: Low Return
DuPont ROE decomposition for CRIN.DE (quarterly period ending 2025-06-30)
ROE: 5.199228497670149%
Net margin: 48.03374803374803%
Asset turnover: 0.008764968051182195
Equity multiplier (leverage): 12.349292901694021
Tax burden factor: 0.7824365245748893
ROE archetype: Standard Business
DuPont ROE decomposition for CRIN.DE (quarterly period ending 2025-12-31)
ROE: 3.1567046939464674%
Net margin: 40.201944652206436%
Asset turnover: 0.0061454452689953774
Equity multiplier (leverage): 12.777136648607375
Tax burden factor: 1.2478235635519443
ROE archetype: Low Return
DuPont ROE decomposition for CRIN.DE (quarterly period ending 2026-03-31)
ROE: 4.735827297899676%
Net margin: 46.37353315424855%
Asset turnover: 0.007890102184700862
Equity multiplier (leverage): 12.943241160794082
Tax burden factor: 0.7608443516585479
ROE archetype: Low Return
DuPont ROE decomposition for CRLA.PA (quarterly period ending 2025-12-31)
Equity multiplier (leverage): 5.99150908553274
ROE archetype: Standard Business
DuPont ROE decomposition for CRMD (annual period ending 2022-12-31)
ROE: -53.94451037687503%
Net margin: -45409.89634295499%
Asset turnover: 0.0010543171432325334
Equity multiplier (leverage): 1.1267445779253282
EBIT margin: -46819.91193737769%
ROE archetype: Low Return
DuPont ROE decomposition for CRMD (annual period ending 2023-12-31)
ROE: -74.02304425007347%
Asset turnover: 0
Equity multiplier (leverage): 1.1509243150867239
ROE archetype: Low Return
DuPont ROE decomposition for CRMD (annual period ending 2024-12-31)
ROE: -23.165460125825142%
Net margin: -41.24493927125506%
Asset turnover: 0.43275969164020356
Equity multiplier (leverage): 1.2978468867608033
EBIT margin: -51.426205373573794%
ROE archetype: Low Return
DuPont ROE decomposition for CRMD (annual period ending 2025-12-31)
ROE: 66.55795119641444%
Net margin: 52.310007089946076%
Asset turnover: 0.6597099645709786
Equity multiplier (leverage): 1.9286886383489399
EBIT margin: 48.16704041269261%
Interest burden factor: 0.9991674492643582
Tax burden factor: 1.0869173954778157
ROE archetype: Balanced Compounder
DuPont ROE decomposition for CRML (annual period ending 2021-06-30)
ROE: -1.7703037080496888%
Asset turnover: 0
Equity multiplier (leverage): 1.019996252862328
ROE archetype: Low Return
DuPont ROE decomposition for CRML (annual period ending 2022-06-30)
ROE: -0.9695076934900274%
Asset turnover: 0
Equity multiplier (leverage): 1.0148368391734781
ROE archetype: Low Return
DuPont ROE decomposition for CRML (annual period ending 2023-06-30)
ROE: -17.564905954642644%
Asset turnover: 0
Equity multiplier (leverage): 1.0582322038482044
ROE archetype: Low Return
DuPont ROE decomposition for CRML (annual period ending 2024-06-30)
ROE: -1353.0076446770338%
Asset turnover: 0
Equity multiplier (leverage): 4.576738094542733
ROE archetype: Low Return
DuPont ROE decomposition for CRON (quarterly period ending 2025-03-31)
ROE: 0.6927917543159321%
Net margin: 18.43286075707671%
Asset turnover: 0.03631220278256619
Equity multiplier (leverage): 1.0350405690885522
EBIT margin: -8.394195426989356%
Tax burden factor: 1.0626031920748487
ROE archetype: Low Return
DuPont ROE decomposition for CRON (quarterly period ending 2025-06-30)
ROE: -3.5012320312779575%
Net margin: -86.96104130886741%
Asset turnover: 0.038806622206926426
Equity multiplier (leverage): 1.03750528766792
EBIT margin: -10.295579860797252%
ROE archetype: Low Return
DuPont ROE decomposition for CRON (quarterly period ending 2025-09-30)
ROE: 2.485656245022352%
Net margin: 58.001556483984594%
Asset turnover: 0.041191270324052356
Equity multiplier (leverage): 1.0403901546326626
EBIT margin: -10.293274350782339%
Tax burden factor: 1.0487317163488243
ROE archetype: Low Return
DuPont ROE decomposition for CRON (quarterly period ending 2025-12-31)
ROE: -0.04347596012044947%
Net margin: -0.840969427078873%
Asset turnover: 0.04950829909887497
Equity multiplier (leverage): 1.0442175020574305
EBIT margin: -10.958294082384175%
ROE archetype: Low Return
DuPont ROE decomposition for CRON (quarterly period ending 2026-03-31)
ROE: 1.3760705328345593%
Net margin: 26.644619689646397%
Asset turnover: 0.049410793231283355
Equity multiplier (leverage): 1.045223927659816
EBIT margin: -2.4675655049605694%
Tax burden factor: 0.8661447709355533
ROE archetype: Low Return
DuPont ROE decomposition for CRON.TO (quarterly period ending 2025-03-31)
ROE: 0.6927917543159321%
Net margin: 18.43286075707671%
Asset turnover: 0.03631220278256619
Equity multiplier (leverage): 1.0350405690885522
EBIT margin: -8.394195426989356%
Tax burden factor: 1.0626031920748487
ROE archetype: Low Return
DuPont ROE decomposition for CRON.TO (quarterly period ending 2025-06-30)
ROE: -3.5012320312779575%
Net margin: -86.96104130886741%
Asset turnover: 0.038806622206926426
Equity multiplier (leverage): 1.03750528766792
EBIT margin: -10.295579860797252%
ROE archetype: Low Return
DuPont ROE decomposition for CRON.TO (quarterly period ending 2025-09-30)
ROE: 2.485656245022352%
Net margin: 58.001556483984594%
Asset turnover: 0.041191270324052356
Equity multiplier (leverage): 1.0403901546326626
EBIT margin: -10.293274350782339%
Tax burden factor: 1.0487317163488243
ROE archetype: Low Return
DuPont ROE decomposition for CRON.TO (quarterly period ending 2025-12-31)
ROE: -0.04347596012044947%
Net margin: -0.840969427078873%
Asset turnover: 0.04950829909887497
Equity multiplier (leverage): 1.0442175020574305
EBIT margin: -10.958294082384175%
ROE archetype: Low Return
DuPont ROE decomposition for CRON.TO (quarterly period ending 2026-03-31)
ROE: 1.3760705328345593%
Net margin: 26.644619689646397%
Asset turnover: 0.049410793231283355
Equity multiplier (leverage): 1.045223927659816
EBIT margin: -2.4675655049605694%
Tax burden factor: 0.8661447709355533
ROE archetype: Low Return
DuPont ROE decomposition for CRRX.TO (annual period ending 2022-12-31)
ROE: -53.29599578013252%
Net margin: -8.999363419407064%
Asset turnover: 1.4430113217532652
Equity multiplier (leverage): 4.104053865367611
EBIT margin: 1.999596570323818%
Interest burden factor: -4.702738110834534
ROE archetype: Low Return
DuPont ROE decomposition for CRRX.TO (annual period ending 2023-12-31)
ROE: -7.502401017357749%
Net margin: -1.4578714267989406%
Asset turnover: 1.5174372338730602
Equity multiplier (leverage): 3.3913320466670007
EBIT margin: 1.9490432803051145%
Interest burden factor: -1.3278438970384723
ROE archetype: Low Return
DuPont ROE decomposition for CRRX.TO (annual period ending 2024-12-31)
ROE: -5.217104049408522%
Net margin: -1.227387010040522%
Asset turnover: 1.544854411876993
Equity multiplier (leverage): 2.7514423536661816
EBIT margin: 2.0329193867700717%
Interest burden factor: -0.5994634473507713
ROE archetype: Low Return
DuPont ROE decomposition for CRRX.TO (annual period ending 2025-12-31)
ROE: 27.473481070954858%
Net margin: 7.056754924495126%
Asset turnover: 1.6199357505149417
Equity multiplier (leverage): 2.4033159342117902
EBIT margin: 3.209531089209461%
Interest burden factor: 0.28216780274341496
Tax burden factor: 7.7921264539218615
ROE archetype: Balanced Compounder
DuPont ROE decomposition for CRS.L (quarterly period ending 2025-12-31)
Equity multiplier (leverage): 1.0305616488003913
ROE archetype: Standard Business
DuPont ROE decomposition for CRSR (quarterly period ending 2025-03-31)
ROE: -1.615133837751808%
Net margin: -2.7226504394861393%
Asset turnover: 0.298316117461114
Equity multiplier (leverage): 1.9885655519403425
EBIT margin: -0.6120351588911427%
ROE archetype: Low Return
DuPont ROE decomposition for CRSR (quarterly period ending 2025-06-30)
ROE: -2.745499865559165%
Net margin: -5.310953666216824%
Asset turnover: 0.26011228856511726
Equity multiplier (leverage): 1.98741262355032
EBIT margin: -5.286587194481932%
ROE archetype: Low Return
DuPont ROE decomposition for CRSR (quarterly period ending 2025-09-30)
ROE: -1.555624085250941%
Net margin: -2.757380055124464%
Asset turnover: 0.28570979999413315
Equity multiplier (leverage): 1.9746170903270335
EBIT margin: -1.6274153104872413%
ROE archetype: Low Return
DuPont ROE decomposition for CRSR (quarterly period ending 2025-12-31)
ROE: 4.147002894942328%
Net margin: 5.963076993510433%
Asset turnover: 0.35628432770606
Equity multiplier (leverage): 1.9519433205792431
EBIT margin: 6.155131565393552%
Interest burden factor: 0.933244077503812
Tax burden factor: 1.0380967561967005
ROE archetype: Low Return
DuPont ROE decomposition for CRSR (quarterly period ending 2026-03-31)
ROE: 1.998678976826988%
Net margin: 3.6830911224443743%
Asset turnover: 0.29164452327400825
Equity multiplier (leverage): 1.8607017036300584
EBIT margin: 3.891546689533781%
Interest burden factor: 0.9350536387358654
Tax burden factor: 1.0121705426356589
ROE archetype: Low Return
DuPont ROE decomposition for CRSU.PA (annual period ending 2022-12-31)
ROE: 4.045930384984768%
Net margin: 27.83105157211974%
Asset turnover: 0.015188140817016811
Equity multiplier (leverage): 9.5715919288804
Tax burden factor: 0.8470931357444339
ROE archetype: Low Return
DuPont ROE decomposition for CRSU.PA (annual period ending 2023-12-31)
ROE: 3.0819540862964767%
Net margin: 23.278539465887498%
Asset turnover: 0.014476517091127539
Equity multiplier (leverage): 9.14547672054727
Tax burden factor: 0.9212311113357254
ROE archetype: Low Return
DuPont ROE decomposition for CRSU.PA (annual period ending 2024-12-31)
ROE: 2.8114619425777994%
Net margin: 23.677448095862516%
Asset turnover: 0.014058806101941056
Equity multiplier (leverage): 8.445957166539273
Tax burden factor: 0.9259714949407457
ROE archetype: Low Return
DuPont ROE decomposition for CRSU.PA (annual period ending 2025-12-31)
ROE: 3.1841576700133434%
Net margin: 25.201340544407884%
Asset turnover: 0.01629649995897189
Equity multiplier (leverage): 7.753121353669933
Tax burden factor: 0.907989349794797
ROE archetype: Low Return
DuPont ROE decomposition for CRT (quarterly period ending 2025-03-31)
ROE: 76.01855189852704%
Net margin: 86.87753056646703%
Asset turnover: 0.4789744216554733
Equity multiplier (leverage): 1.8268370155033804
EBIT margin: 86.29284004920635%
Interest burden factor: 1.0067756550477107
Tax burden factor: 1
ROE archetype: Balanced Compounder
DuPont ROE decomposition for CRT (quarterly period ending 2025-06-30)
ROE: 38.49879592594653%
Net margin: 68.98836420187267%
Asset turnover: 0.3257952895179448
Equity multiplier (leverage): 1.7128782653742118
EBIT margin: 68.06223072796782%
Interest burden factor: 1.0136071572147913
Tax burden factor: 1
ROE archetype: High-Margin Compounder
DuPont ROE decomposition for CRT (quarterly period ending 2025-09-30)
ROE: 20.04438950720307%
Net margin: 59.52554782864466%
Asset turnover: 0.206417534236476
Equity multiplier (leverage): 1.6313338452195056
EBIT margin: 57.854092694917746%
Interest burden factor: 1.0288908710839353
Tax burden factor: 1
ROE archetype: High-Margin Compounder
DuPont ROE decomposition for CRT (quarterly period ending 2025-12-31)
ROE: 61.98495872838474%
Net margin: 83.52357247006495%
Asset turnover: 0.4063526579233978
Equity multiplier (leverage): 1.8263085398508079
EBIT margin: 82.72794330628255%
Interest burden factor: 1.0096174174285555
Tax burden factor: 1
ROE archetype: Balanced Compounder
DuPont ROE decomposition for CRT (quarterly period ending 2026-03-31)
ROE: 23.503732585431127%
Net margin: 65.02432893599817%
Asset turnover: 0.19531790648982503
Equity multiplier (leverage): 1.8506270155237643
EBIT margin: 63.25910865805283%
Interest burden factor: 1.0279046024421121
Tax burden factor: 1
ROE archetype: Balanced Compounder
DuPont ROE decomposition for CRTM.L (annual period ending 2022-06-30)
ROE: -81.83841889099266%
Asset turnover: 0
Equity multiplier (leverage): 1.137138772466383
ROE archetype: Low Return
DuPont ROE decomposition for CRTM.L (annual period ending 2023-06-30)
ROE: -158.8295464863432%
Asset turnover: 0
Equity multiplier (leverage): 1.7797494370926459
ROE archetype: Low Return
DuPont ROE decomposition for CRTM.L (annual period ending 2024-06-30)
ROE: -213.51172759912572%
Asset turnover: 0
Equity multiplier (leverage): 3.9708674251081546
ROE archetype: Low Return
DuPont ROE decomposition for CRTM.L (annual period ending 2025-06-30)
Asset turnover: 0
ROE archetype: Standard Business
DuPont ROE decomposition for CRTO (annual period ending 2022-12-31)
ROE: 1.0059143136750697%
Net margin: 0.5391662778885307%
Asset turnover: 0.858703287589819
Equity multiplier (leverage): 2.1726768697981513
EBIT margin: 1.2036670247887582%
Interest burden factor: 1.732473844633001
Tax burden factor: 0.25855305389791017
ROE archetype: Low Return
DuPont ROE decomposition for CRTO (annual period ending 2023-12-31)
ROE: 5.091469014759923%
Net margin: 2.8030542026063827%
Asset turnover: 0.8401892787983375
Equity multiplier (leverage): 2.1618943866930187
EBIT margin: 3.9610248044956387%
Interest burden factor: 0.9677536325727162
Tax burden factor: 0.7312386254148379
ROE archetype: Standard Business
DuPont ROE decomposition for CRTO (annual period ending 2024-12-31)
ROE: 10.122119041513074%
Net margin: 5.933567097314473%
Asset turnover: 0.8026217937655035
Equity multiplier (leverage): 2.1254193725167987
EBIT margin: 7.831317511246379%
Interest burden factor: 1.020442266284461
Tax burden factor: 0.742493381748513
ROE archetype: Standard Business
DuPont ROE decomposition for CRTO (annual period ending 2025-12-31)
ROE: 13.941433905842496%
Net margin: 7.680545179420443%
Asset turnover: 0.9243916730141996
Equity multiplier (leverage): 1.9636287013558398
EBIT margin: 10.425466386206805%
Interest burden factor: 1.0039898404557
Tax burden factor: 0.733782310118188
ROE archetype: Standard Business
DuPont ROE decomposition for CRWN.L (annual period ending 2021-06-30)
ROE: 14.762395363811978%
Net margin: 96.74234112583339%
Asset turnover: 0.1498109820085216
Equity multiplier (leverage): 1.018583386992917
Tax burden factor: 1
ROE archetype: Standard Business
DuPont ROE decomposition for CRWN.L (annual period ending 2022-06-30)
ROE: 5.610713924806028%
Net margin: 92.59469696969697%
Asset turnover: 0.05961348146589325
Equity multiplier (leverage): 1.016453522826639
Tax burden factor: 1
ROE archetype: Standard Business
DuPont ROE decomposition for CRWN.L (annual period ending 2023-06-30)
ROE: 3.189040680583808%
Net margin: 86.70360110803324%
Asset turnover: 0.036389545896935896
Equity multiplier (leverage): 1.0107559057977091
Tax burden factor: 1
ROE archetype: Low Return
DuPont ROE decomposition for CRWN.L (annual period ending 2024-06-30)
ROE: 2.2668614178092588%
Net margin: 80.8741128128502%
Asset turnover: 0.027524445038505437
Equity multiplier (leverage): 1.0183495364189872
Tax burden factor: 1
ROE archetype: Low Return
DuPont ROE decomposition for CSAI (annual period ending 2022-12-31)
ROE: -95.70299637800461%
Net margin: -2377.5051124744377%
Asset turnover: 0.03967223754664936
Equity multiplier (leverage): 1.0146526177148503
EBIT margin: -2377.5051124744377%
ROE archetype: Low Return
DuPont ROE decomposition for CSAI (annual period ending 2023-12-31)
ROE: -107.02953235486363%
Net margin: -1483.690280065898%
Asset turnover: 0.07025462962962963
Equity multiplier (leverage): 1.026798977954721
EBIT margin: -1469.6869851729818%
ROE archetype: Low Return
DuPont ROE decomposition for CSAI (annual period ending 2024-12-31)
ROE: -312.9039980847498%
Net margin: -479.10557184750735%
Asset turnover: 0.48985455198419825
Equity multiplier (leverage): 1.3332535312425187
EBIT margin: -454.3255131964809%
ROE archetype: Low Return
DuPont ROE decomposition for CSAI (annual period ending 2025-12-31)
ROE: -201.33238163216748%
Net margin: -167.03513620213187%
Asset turnover: 0.9436527894197634
Equity multiplier (leverage): 1.277301927194861
EBIT margin: -160.89617054875643%
ROE archetype: Low Return
DuPont ROE decomposition for CSBBANK.NS (annual period ending 2023-03-31)
ROE: 17.085681401551703%
Net margin: 33.18134550690838%
Asset turnover: 0.05656641782296765
Equity multiplier (leverage): 9.10289711059942
Tax burden factor: 0.7461207233219518
ROE archetype: Leverage-Driven Returns
DuPont ROE decomposition for CSBBANK.NS (annual period ending 2024-03-31)
ROE: 16.06271453952892%
Net margin: 27.504538947018638%
Asset turnover: 0.06275702446845291
Equity multiplier (leverage): 9.305768148865225
Tax burden factor: 0.7444059750323694
ROE archetype: Leverage-Driven Returns
DuPont ROE decomposition for CSBBANK.NS (annual period ending 2025-03-31)
ROE: 14.13902824293273%
Net margin: 24.254257157211534%
Asset turnover: 0.057726382825707676
Equity multiplier (leverage): 10.09850858307154
Tax burden factor: 0.7426863282178279
ROE archetype: Standard Business
DuPont ROE decomposition for CSBBANK.NS (annual period ending 2026-03-31)
ROE: 12.848918605060947%
Net margin: 21.85700675199867%
Asset turnover: 0.0524352315026171
Equity multiplier (leverage): 11.211215530866966
Tax burden factor: 0.7439024390243902
ROE archetype: Standard Business
DuPont ROE decomposition for CSBR (annual period ending 2022-04-30)
ROE: 6.024626209322779%
Net margin: 1.1158850719827322%
Asset turnover: 1.3881225620442084
Equity multiplier (leverage): 3.889401934916447
EBIT margin: 1.2360259830173697%
Interest burden factor: 0.9604612850082372
Tax burden factor: 0.9399656946826758
ROE archetype: Standard Business
DuPont ROE decomposition for CSBR (annual period ending 2023-04-30)
ROE: -77.70171861345761%
Net margin: -9.90347131984407%
Asset turnover: 1.5460115656703353
Equity multiplier (leverage): 5.074934459656277
EBIT margin: -8.258771115648784%
ROE archetype: Low Return
DuPont ROE decomposition for CSBR (annual period ending 2024-04-30)
ROE: -532.4551774606659%
Net margin: -14.507028212541123%
Asset turnover: 1.6595801002597488
Equity multiplier (leverage): 22.11598975484815
EBIT margin: -13.799222410527365%
ROE archetype: Low Return
DuPont ROE decomposition for CSBR (annual period ending 2025-04-30)
ROE: 503.04975922953446%
Net margin: 8.255479067153695%
Asset turnover: 1.9476024351870853
Equity multiplier (leverage): 31.287319422150883
EBIT margin: 8.51011520089913%
Interest burden factor: 0.9546017333883615
Tax burden factor: 1.01621271076524
ROE archetype: Leverage-Driven Returns
DuPont ROE decomposition for CSIQ (quarterly period ending 2025-03-31)
ROE: -0.8345348201061698%
Net margin: -2.8389010759427555%
Asset turnover: 0.08611577327916344
Equity multiplier (leverage): 3.41359109390611
EBIT margin: -4.579964483443017%
ROE archetype: Low Return
DuPont ROE decomposition for CSIQ (quarterly period ending 2025-06-30)
ROE: 1.1087563893446228%
Net margin: 2.643058414719893%
Asset turnover: 0.12045544971668805
Equity multiplier (leverage): 3.4825945855151494
EBIT margin: 7.523182107728392%
Interest burden factor: 0.6366796669622469
Tax burden factor: 0.5518031897848005
ROE archetype: Low Return
DuPont ROE decomposition for CSIQ (quarterly period ending 2025-09-30)
ROE: 0.20907577657784224%
Net margin: 0.6041406425431727%
Asset turnover: 0.09855185953079605
Equity multiplier (leverage): 3.511566055191182
EBIT margin: 2.325464131418406%
Interest burden factor: -0.22018560814131657
ROE archetype: Low Return
DuPont ROE decomposition for CSIQ (quarterly period ending 2025-12-31)
ROE: -1.4012588249083717%
Net margin: -4.930624075240981%
Asset turnover: 0.08084908803693806
Equity multiplier (leverage): 3.51512961241082
EBIT margin: -5.262941696947689%
ROE archetype: Low Return
DuPont ROE decomposition for CSIQ (quarterly period ending 2026-03-31)
ROE: -0.31309636566365034%
Net margin: -1.2532030526645874%
Asset turnover: 0.06970294175782432
Equity multiplier (leverage): 3.584309264887557
EBIT margin: 6.76013426380351%
Interest burden factor: 0.11919139241896083
Tax burden factor: -1.5553252734599887
ROE archetype: Low Return
DuPont ROE decomposition for CSL.AX (quarterly period ending 2024-12-31)
ROE: 10.006813978389955%
Net margin: 25.033483501765495%
Asset turnover: 0.21361874788670118
Equity multiplier (leverage): 1.8712644797040785
EBIT margin: 24.07159381468404%
Interest burden factor: 1.2847749114820435
Tax burden factor: 0.8094488188976378
ROE archetype: Standard Business
DuPont ROE decomposition for CSX.AX (annual period ending 2022-06-30)
ROE: -37.916635017473716%
Net margin: -84.45289048916406%
Asset turnover: 0.34827072507114937
Equity multiplier (leverage): 1.2891347032224367
EBIT margin: -113.1865547139455%
ROE archetype: Low Return
DuPont ROE decomposition for CSX.AX (annual period ending 2023-06-30)
ROE: -30.72008716652007%
Net margin: -67.24416128226116%
Asset turnover: 0.3509263150422999
Equity multiplier (leverage): 1.3018229589408972
EBIT margin: -97.8391811612983%
ROE archetype: Low Return
DuPont ROE decomposition for CSX.AX (annual period ending 2024-06-30)
ROE: -15.287124741977845%
Net margin: -19.890602168302273%
Asset turnover: 0.5734171591888632
Equity multiplier (leverage): 1.3403159735155334
EBIT margin: -30.171111891773034%
ROE archetype: Low Return
DuPont ROE decomposition for CSX.AX (annual period ending 2025-06-30)
ROE: -2.4753881640158255%
Net margin: -2.4198416940369234%
Asset turnover: 0.7300567159448705
Equity multiplier (leverage): 1.4011987918423054
EBIT margin: -7.69768867465354%
ROE archetype: Low Return
DuPont ROE decomposition for CTHT.L (quarterly period ending 2024-11-30)
Equity multiplier (leverage): 1.5821747084381432
ROE archetype: Standard Business
DuPont ROE decomposition for CTHT.L (quarterly period ending 2025-05-31)
Equity multiplier (leverage): 1.3758184032486787
ROE archetype: Standard Business
DuPont ROE decomposition for CTHT.L (quarterly period ending 2025-11-30)
Equity multiplier (leverage): 1.0168746476512622
ROE archetype: Standard Business
DuPont ROE decomposition for CTO.DE (annual period ending 2022-08-31)
ROE: 28.64822976703637%
Net margin: 2.6062550120288694%
Asset turnover: 3.5369822024124926
Equity multiplier (leverage): 3.1077638397830194
EBIT margin: 3.4337354706240033%
Interest burden factor: 1.0060310535095598
Tax burden factor: 0.7544642857142857
ROE archetype: Leverage-Driven Returns
DuPont ROE decomposition for CTO.DE (annual period ending 2023-08-31)
ROE: 27.53309265944645%
Net margin: 2.59688802674481%
Asset turnover: 3.6390808050465604
Equity multiplier (leverage): 2.9134667979433324
EBIT margin: 3.3488794419910026%
Interest burden factor: 1.0459699285186097
Tax burden factor: 0.741369152821963
ROE archetype: Leverage-Driven Returns
DuPont ROE decomposition for CTO.DE (annual period ending 2024-08-31)
ROE: 30.267050123253902%
Net margin: 2.8952301603832535%
Asset turnover: 3.6658094723572843
Equity multiplier (leverage): 2.8517871815940836
EBIT margin: 3.6490039417888567%
Interest burden factor: 1.0490037695207324
Tax burden factor: 0.7563655030800821
ROE archetype: Leverage-Driven Returns
DuPont ROE decomposition for CTO.DE (annual period ending 2025-08-31)
ROE: 30.686166786647973%
Net margin: 2.9425763438516177%
Asset turnover: 3.7464779146532363
Equity multiplier (leverage): 2.7835032016064867
EBIT margin: 3.7724126655403563%
Interest burden factor: 1.041895405952037
Tax burden factor: 0.7486596413385099
ROE archetype: Leverage-Driven Returns
DuPont ROE decomposition for CTP.AX (annual period ending 2022-06-30)
ROE: 80.36185450433469%
Net margin: 50.580057412635526%
Asset turnover: 0.34466940324136913
Equity multiplier (leverage): 4.609649453448924
EBIT margin: -27.74074161941591%
Tax burden factor: 1
ROE archetype: Leverage-Driven Returns
DuPont ROE decomposition for CTP.AX (annual period ending 2023-06-30)
ROE: -33.860962347208336%
Net margin: -20.277671634186728%
Asset turnover: 0.3481821243968071
Equity multiplier (leverage): 4.795951030394774
EBIT margin: -12.846771111960258%
ROE archetype: Low Return
DuPont ROE decomposition for CTP.AX (annual period ending 2024-06-30)
ROE: 47.94787324394603%
Net margin: 33.43381600904344%
Asset turnover: 0.36947073145537646
Equity multiplier (leverage): 3.8815336902264246
EBIT margin: 6.494590084513108%
Interest burden factor: 5.147948611686696
Tax burden factor: 1
ROE archetype: Leverage-Driven Returns
DuPont ROE decomposition for CTP.AX (annual period ending 2025-06-30)
ROE: 20.871367446981623%
Net margin: 17.727960390592763%
Asset turnover: 0.3970985753112385
Equity multiplier (leverage): 2.964789080178273
EBIT margin: 24.04987851281346%
Interest burden factor: 0.737133053755242
Tax burden factor: 1
ROE archetype: Leverage-Driven Returns
DuPont ROE decomposition for CTSO (quarterly period ending 2025-03-31)
ROE: -10.16999221056986%
Net margin: -16.947404606393953%
Asset turnover: 0.17185330049314632
Equity multiplier (leverage): 3.491881884513997
EBIT margin: -44.55139223100722%
ROE archetype: Low Return
DuPont ROE decomposition for CTSO (quarterly period ending 2025-06-30)
ROE: 14.903104560855185%
Net margin: 20.245398773006134%
Asset turnover: 0.1947319233718846
Equity multiplier (leverage): 3.780186785577163
EBIT margin: -37.58968493293126%
Tax burden factor: 1
ROE archetype: Standard Business
DuPont ROE decomposition for CTSO (quarterly period ending 2025-09-30)
ROE: -30.767737552169272%
Net margin: -33.42119135477069%
Asset turnover: 0.20236825261361213
Equity multiplier (leverage): 4.5491604387071725
EBIT margin: -30.173958882445966%
ROE archetype: Low Return
DuPont ROE decomposition for CTSO (quarterly period ending 2025-12-31)
ROE: -73.67151377068954%
Net margin: -59.5299978340914%
Asset turnover: 0.20535515722990705
Equity multiplier (leverage): 6.026402197949474
EBIT margin: -41.964479098982025%
ROE archetype: Low Return
DuPont ROE decomposition for CTSO (quarterly period ending 2026-03-31)
ROE: -126.68889712239103%
Net margin: -57.863267148014444%
Asset turnover: 0.209194751250826
Equity multiplier (leverage): 10.466098555020379
EBIT margin: -34.34115523465704%
ROE archetype: Low Return
DuPont ROE decomposition for CTUK.L (annual period ending 2022-09-30)
ROE: -15.281335749941777%
Asset turnover: -0.13689317997093667
Equity multiplier (leverage): 1.0962761953942681
ROE archetype: Low Return
DuPont ROE decomposition for CTUK.L (annual period ending 2023-09-30)
ROE: 13.108743198433459%
Net margin: 97.78271075729742%
Asset turnover: 0.12300175930511859
Equity multiplier (leverage): 1.0899025275074685
Tax burden factor: 0.999426261572565
ROE archetype: Standard Business
DuPont ROE decomposition for CTUK.L (annual period ending 2024-09-30)
ROE: 17.583614690007725%
Net margin: 98.36045255758779%
Asset turnover: 0.1649540429684296
Equity multiplier (leverage): 1.0837389336102599
Tax burden factor: 0.9994962307263274
ROE archetype: High-Margin Compounder
DuPont ROE decomposition for CTUK.L (annual period ending 2025-09-30)
ROE: 5.584804627340204%
Net margin: 94.82386049550229%
Asset turnover: 0.055313257311987885
Equity multiplier (leverage): 1.0647830233304874
Tax burden factor: 0.9979901623737241
ROE archetype: Standard Business
DuPont ROE decomposition for CTY.L (annual period ending 2022-06-30)
ROE: 5.523257917343154%
Net margin: 97.90638936027467%
Asset turnover: 0.05237852106489281
Equity multiplier (leverage): 1.0770380768282426
Tax burden factor: 0.9876978202448492
ROE archetype: Standard Business
DuPont ROE decomposition for CTY.L (annual period ending 2023-06-30)
ROE: 3.3678130334598078%
Net margin: 96.24933387668099%
Asset turnover: 0.03263744076586261
Equity multiplier (leverage): 1.0720971565964093
Tax burden factor: 0.9776168112711933
ROE archetype: Low Return
DuPont ROE decomposition for CTY.L (annual period ending 2024-06-30)
ROE: 14.82117495801586%
Net margin: 99.45294160920771%
Asset turnover: 0.13893420469768336
Equity multiplier (leverage): 1.072644527609869
Tax burden factor: 0.9982111152504942
ROE archetype: Standard Business
DuPont ROE decomposition for CTY.L (annual period ending 2025-06-30)
ROE: 16.02318892991528%
Net margin: 99.38356602118303%
Asset turnover: 0.15104076383294998
Equity multiplier (leverage): 1.0674319663703007
Tax burden factor: 0.997632156021089
ROE archetype: High-Margin Compounder
DuPont ROE decomposition for CTZ.V (quarterly period ending 2024-10-31)
ROE: 6.7702620677904735%
Net margin: 30.173393383643717%
Asset turnover: 0.20074628796655583
Equity multiplier (leverage): 1.1177220063951085
EBIT margin: 36.54323131575868%
Interest burden factor: 1.1424040685190076
Tax burden factor: 0.7227655877584503
ROE archetype: Standard Business
DuPont ROE decomposition for CTZ.V (quarterly period ending 2025-01-31)
ROE: 7.975438994012252%
Net margin: 36.15473320378469%
Asset turnover: 0.1937300735811069
Equity multiplier (leverage): 1.1386556169556068
EBIT margin: 41.461145964721084%
Interest burden factor: 1.1947479239517278
Tax burden factor: 0.7298734651015294
ROE archetype: Standard Business
DuPont ROE decomposition for CTZ.V (quarterly period ending 2025-04-30)
ROE: 6.1588021247532%
Net margin: 27.725954483273224%
Asset turnover: 0.19426493399319258
Equity multiplier (leverage): 1.1434451325850383
EBIT margin: 43.40380549682875%
Interest burden factor: 0.8737835592103377
Tax burden factor: 0.7310630405641149
ROE archetype: Standard Business
DuPont ROE decomposition for CTZ.V (quarterly period ending 2025-10-31)
ROE: 6.023780993649361%
Net margin: 30.482789231413303%
Asset turnover: 0.17919885940175984
Equity multiplier (leverage): 1.1027554925427867
EBIT margin: 38.34748349257926%
Interest burden factor: 1.086791202813986
Tax burden factor: 0.7314282325733092
ROE archetype: Standard Business
DuPont ROE decomposition for CTZ.V (quarterly period ending 2026-01-31)
ROE: 6.065066530711784%
Net margin: 30.78961982309179%
Asset turnover: 0.17756468476838108
Equity multiplier (leverage): 1.1093654805440565
EBIT margin: 44.11190908558374%
Interest burden factor: 0.9521137414173908
Tax burden factor: 0.7330939570506283
ROE archetype: Standard Business
DuPont ROE decomposition for CTZ.V (quarterly period ending 2026-04-30)
ROE: 6.774388709947529%
Net margin: 30.702717701312988%
Asset turnover: 0.1941068797870215
Equity multiplier (leverage): 1.1367170249479253
EBIT margin: 39.29007827868449%
Interest burden factor: 1.063402309052258
Tax burden factor: 0.734845986264519
ROE archetype: Standard Business
DuPont ROE decomposition for CURN.SW (quarterly period ending 2024-12-31)
Equity multiplier (leverage): 1.2179481556208607
ROE archetype: Standard Business
DuPont ROE decomposition for CURN.SW (quarterly period ending 2025-06-30)
Equity multiplier (leverage): 1.2208536164967407
ROE archetype: Standard Business
DuPont ROE decomposition for CURN.SW (quarterly period ending 2025-12-31)
Equity multiplier (leverage): 1.2188150094912469
ROE archetype: Standard Business
DuPont ROE decomposition for CVBF (annual period ending 2022-12-31)
ROE: 12.082265640997743%
Net margin: 42.588890798411676%
Asset turnover: 0.0335498229604031
Equity multiplier (leverage): 8.455938541978336
Tax burden factor: 0.7170006121572604
ROE archetype: Standard Business
DuPont ROE decomposition for CVBF (annual period ending 2023-12-31)
ROE: 10.998912452014647%
Net margin: 40.45805013520427%
Asset turnover: 0.03368378762781778
Equity multiplier (leverage): 8.070935497402328
Tax burden factor: 0.7020010525181178
ROE archetype: Standard Business
DuPont ROE decomposition for CVBF (annual period ending 2024-12-31)
ROE: 9.413810699464952%
Net margin: 42.17422639471677%
Asset turnover: 0.03053256607741008
Equity multiplier (leverage): 7.310633803345365
Tax burden factor: 0.7399995575841143
ROE archetype: Standard Business
DuPont ROE decomposition for CVBF (annual period ending 2025-12-31)
ROE: 9.340449934620688%
Net margin: 40.60427813711301%
Asset turnover: 0.03348792415091531
Equity multiplier (leverage): 6.869225534079803
Tax burden factor: 0.7430003585463607
ROE archetype: Standard Business
DuPont ROE decomposition for CVCG.L (quarterly period ending 2024-12-31)
Equity multiplier (leverage): 1.0007083261879375
ROE archetype: Standard Business
DuPont ROE decomposition for CVCG.L (quarterly period ending 2025-06-30)
Equity multiplier (leverage): 1.0009150340301507
ROE archetype: Standard Business
DuPont ROE decomposition for CVCG.L (quarterly period ending 2025-12-31)
Equity multiplier (leverage): 1.001079570350315
ROE archetype: Standard Business
DuPont ROE decomposition for CVCO (quarterly period ending 2025-03-31)
ROE: 3.4126070138326594%
Net margin: 7.146538463051629%
Asset turnover: 0.36139750967728174
Equity multiplier (leverage): 1.3213120266921665
EBIT margin: 7.598975525122059%
Interest burden factor: 1.1111312451462594
Tax burden factor: 0.8463993663071081
ROE archetype: Low Return
DuPont ROE decomposition for CVCO (quarterly period ending 2025-06-30)
ROE: 4.850346221849663%
Net margin: 9.273835113862267%
Asset turnover: 0.394059007975906
Equity multiplier (leverage): 1.3272480939600781
EBIT margin: 10.83904844511248%
Interest burden factor: 1.081828423738361
Tax burden factor: 0.7908786008545569
ROE archetype: Low Return
DuPont ROE decomposition for CVCO (quarterly period ending 2025-09-30)
ROE: 4.870453795264462%
Net margin: 9.412121963534563%
Asset turnover: 0.3880013358032214
Equity multiplier (leverage): 1.333670855474507
EBIT margin: 11.172503759925394%
Interest burden factor: 1.0816365917205442
Tax burden factor: 0.7788533024058049
ROE archetype: Low Return
DuPont ROE decomposition for CVCO (quarterly period ending 2025-12-31)
ROE: 4.051474793091338%
Net margin: 7.58475991146208%
Asset turnover: 0.39776891099195416
Equity multiplier (leverage): 1.3428900832783233
EBIT margin: 9.390802658891486%
Interest burden factor: 1.0556818181818182
Tax burden factor: 0.7650786485641863
ROE archetype: Low Return
DuPont ROE decomposition for CVCO (quarterly period ending 2026-03-31)
ROE: 3.873470227389971%
Net margin: 7.71839956955394%
Asset turnover: 0.3712892303061349
Equity multiplier (leverage): 1.3516386828869353
EBIT margin: 9.356566756403522%
Interest burden factor: 1.0597983408777418
Tax burden factor: 0.7783725321259005
ROE archetype: Low Return
DuPont ROE decomposition for CVO.TO (annual period ending 2023-03-31)
ROE: -18.18123578589961%
Net margin: -35.474366529169124%
Asset turnover: 0.36267963654968294
Equity multiplier (leverage): 1.4131412647060169
EBIT margin: -39.65911323012089%
ROE archetype: Low Return
DuPont ROE decomposition for CVO.TO (annual period ending 2024-03-31)
ROE: -11.89252901353965%
Net margin: -18.724126445350294%
Asset turnover: 0.4313095708419488
Equity multiplier (leverage): 1.472595805125725
EBIT margin: -23.553063587482352%
ROE archetype: Low Return
DuPont ROE decomposition for CVO.TO (annual period ending 2025-03-31)
ROE: -8.704178599240706%
Net margin: -10.31949696860556%
Asset turnover: 0.5100415279825576
Equity multiplier (leverage): 1.6537266596648377
EBIT margin: -17.278948316225463%
ROE archetype: Low Return
DuPont ROE decomposition for CVO.TO (annual period ending 2026-03-31)
ROE: -26.822622976704068%
Net margin: -19.46824503333581%
Asset turnover: 0.6790813380898904
Equity multiplier (leverage): 2.0288626428632734
EBIT margin: -18.499517995941726%
ROE archetype: Low Return
DuPont ROE decomposition for CWAN (annual period ending 2022-12-31)
ROE: -1.9785097492213035%
Net margin: -2.2064687930500355%
Asset turnover: 0.6295902826481194
Equity multiplier (leverage): 1.4242374093490866
EBIT margin: 1.6864078885790934%
Interest burden factor: -1.0426030877467265
ROE archetype: Low Return
DuPont ROE decomposition for CWAN (annual period ending 2023-12-31)
ROE: -5.782287916603725%
Net margin: -5.874220464570523%
Asset turnover: 0.7075493545116918
Equity multiplier (leverage): 1.3912101309684068
EBIT margin: -4.548195389061515%
ROE archetype: Low Return
DuPont ROE decomposition for CWAN (annual period ending 2024-12-31)
ROE: 59.39142488860245%
Net margin: 94.63969916091747%
Asset turnover: 0.522824832278838
Equity multiplier (leverage): 1.2003121076083696
EBIT margin: 2.707817345170351%
Interest burden factor: -2.4573320255026974
ROE archetype: High-Margin Compounder
DuPont ROE decomposition for CWAN (annual period ending 2025-12-31)
ROE: -2.5353090804204585%
Net margin: -5.306083941326391%
Asset turnover: 0.3481460554216219
Equity multiplier (leverage): 1.3724461613491945
EBIT margin: -1.0509073407641571%
ROE archetype: Low Return
DuPont ROE decomposition for CWST (quarterly period ending 2025-03-31)
ROE: -0.3109466807249906%
Net margin: -1.153197906502262%
Asset turnover: 0.13010540040613
Equity multiplier (leverage): 2.072462859326041
EBIT margin: 2.062090476886893%
Interest burden factor: -0.9458202534589001
ROE archetype: Low Return
DuPont ROE decomposition for CWST (quarterly period ending 2025-06-30)
ROE: 0.33588406582244196%
Net margin: 1.1191961043035756%
Asset turnover: 0.1440042607044862
Equity multiplier (leverage): 2.0840487315668463
EBIT margin: 5.530221303407875%
Interest burden factor: 0.2676226004507655
Tax burden factor: 0.7562073471758385
ROE archetype: Low Return
DuPont ROE decomposition for CWST (quarterly period ending 2025-09-30)
ROE: 0.6396832337832707%
Net margin: 2.057067977607958%
Asset turnover: 0.14837540198615054
Equity multiplier (leverage): 2.0958221009147713
EBIT margin: 6.995143720729946%
Interest burden factor: 0.4680274513269123
Tax burden factor: 0.6283196979232222
ROE archetype: Low Return
DuPont ROE decomposition for CWST (quarterly period ending 2025-12-31)
ROE: -0.16013657845337148%
Net margin: -0.5353316775218258%
Asset turnover: 0.1423834254770879
Equity multiplier (leverage): 2.1009134672566616
EBIT margin: 4.4335952073850615%
Interest burden factor: -0.07645701096364685
ROE archetype: Low Return
DuPont ROE decomposition for CWST (quarterly period ending 2026-03-31)
ROE: -0.35313983004787053%
Net margin: -1.2111657278802086%
Asset turnover: 0.13913710158926948
Equity multiplier (leverage): 2.0955603775708074
EBIT margin: 2.695658258405346%
Interest burden factor: -0.7157689811810513
ROE archetype: Low Return
DuPont ROE decomposition for CX (annual period ending 2022-12-31)
ROE: 8.112567604730039%
Net margin: 6.017951856385149%
Asset turnover: 0.5560555072408969
Equity multiplier (leverage): 2.4243285360711337
EBIT margin: 9.254725962192303%
Interest burden factor: 0.4188096987509184
Tax burden factor: 1.5526315789473684
ROE archetype: Standard Business
DuPont ROE decomposition for CX (annual period ending 2023-12-31)
ROE: 1.8410643728580613%
Net margin: 1.2131187515240185%
Asset turnover: 0.6374347291876
Equity multiplier (leverage): 2.3808384997693404
EBIT margin: 11.862960253596684%
Interest burden factor: 0.6813977389516958
Tax burden factor: 0.15007541478129713
ROE archetype: Low Return
DuPont ROE decomposition for CX (annual period ending 2024-12-31)
ROE: 7.052731629973528%
Net margin: 5.976467658594285%
Asset turnover: 0.5189559264617234
Equity multiplier (leverage): 2.2739573181875286
EBIT margin: 11.349063064184772%
Interest burden factor: 0.5436094349972572
Tax burden factor: 0.968718466195762
ROE archetype: Standard Business
DuPont ROE decomposition for CX (annual period ending 2025-12-31)
ROE: 7.9143994602209595%
Net margin: 6.012893627572527%
Asset turnover: 0.6117866134657568
Equity multiplier (leverage): 2.151465942268006
EBIT margin: 11.089759484254898%
Interest burden factor: 0.4410285075461151
Tax burden factor: 1.229404309252218
ROE archetype: Standard Business
DuPont ROE decomposition for CXT (quarterly period ending 2025-03-31)
ROE: 1.9609615037050425%
Net margin: 6.569785043899485%
Asset turnover: 0.13599868242269528
Equity multiplier (leverage): 2.1947406470269293
EBIT margin: 11.292764153799578%
Interest burden factor: 0.7533512064343163
Tax burden factor: 0.7722419928825622
ROE archetype: Low Return
DuPont ROE decomposition for CXT (quarterly period ending 2025-06-30)
ROE: 2.1898129899706564%
Net margin: 6.181998021760633%
Asset turnover: 0.15127936555439175
Equity multiplier (leverage): 2.3415232339158236
EBIT margin: 13.649851632047477%
Interest burden factor: 0.5942028985507246
Tax burden factor: 0.7621951219512195
ROE archetype: Low Return
DuPont ROE decomposition for CXT (quarterly period ending 2025-09-30)
ROE: 4.2608404486857525%
Net margin: 11.435632442147831%
Asset turnover: 0.1525516674092607
Equity multiplier (leverage): 2.44240750041855
EBIT margin: 19.186699618063358%
Interest burden factor: 0.7798594847775175
Tax burden factor: 0.7642642642642643
ROE archetype: Low Return
DuPont ROE decomposition for CXT (quarterly period ending 2025-12-31)
ROE: 3.8877414651925646%
Net margin: 10.065003145313483%
Asset turnover: 0.15806831176148886
Equity multiplier (leverage): 2.4436479974081724
EBIT margin: 17.949255609142376%
Interest burden factor: 0.625
Tax burden factor: 0.897196261682243
ROE archetype: Low Return
DuPont ROE decomposition for CXT (quarterly period ending 2026-03-31)
ROE: 0.5406694760276696%
Net margin: 1.7539334537013154%
Asset turnover: 0.1147584655458205
Equity multiplier (leverage): 2.686173173252763
EBIT margin: 6.525664173329894%
Interest burden factor: 0.36363636363636365
Tax burden factor: 0.7391304347826086
ROE archetype: Low Return
DuPont ROE decomposition for CY5.AX (annual period ending 2022-12-31)
ROE: -13.334077673356285%
Net margin: -2508.6542411727823%
Asset turnover: 0.004321999171092723
Equity multiplier (leverage): 1.2298085078984033
EBIT margin: -2818.8793271205864%
ROE archetype: Low Return
DuPont ROE decomposition for CY5.AX (annual period ending 2023-12-31)
ROE: -60.95790234401019%
Net margin: -155175.81609195398%
Asset turnover: 0.00030880189080616065
Equity multiplier (leverage): 1.2721139786174258
EBIT margin: -163497.1609195402%
ROE archetype: Low Return
DuPont ROE decomposition for CY5.AX (annual period ending 2024-12-31)
ROE: -7.442366844081925%
Equity multiplier (leverage): 1.1612618724963695
ROE archetype: Low Return
DuPont ROE decomposition for CY5.AX (annual period ending 2025-12-31)
ROE: -10.040027998656537%
Net margin: -10890.501294486132%
Asset turnover: 0.0008452328299516518
Equity multiplier (leverage): 1.0907135179527732
EBIT margin: -12251.818824523958%
ROE archetype: Low Return
DuPont ROE decomposition for CYAD.BR (annual period ending 2022-12-31)
ROE: -948.2279360667131%
Asset turnover: 0
Equity multiplier (leverage): 4.567060458651842
ROE archetype: Low Return
DuPont ROE decomposition for CYAD.BR (annual period ending 2023-12-31)
ROE: -161.8809792214093%
Net margin: -8282.35294117647%
Asset turnover: 0.005802209293459383
Equity multiplier (leverage): 3.3685942191771323
EBIT margin: -9238.235294117649%
ROE archetype: Low Return
DuPont ROE decomposition for CYAD.BR (annual period ending 2024-12-31)
ROE: -160.98922868542041%
Net margin: -3131.1827956989246%
Asset turnover: 0.013628636745540162
Equity multiplier (leverage): 3.7725584866717643
EBIT margin: -3154.3010752688174%
ROE archetype: Low Return
DuPont ROE decomposition for CYAD.BR (annual period ending 2025-12-31)
ROE: 57.470310972948965%
Net margin: 3952.380952380952%
Asset turnover: 0.003208944295528489
Equity multiplier (leverage): 4.5312974456437445
EBIT margin: -6400%
Tax burden factor: 1
ROE archetype: Leverage-Driven Returns
DuPont ROE decomposition for CYB.AX (quarterly period ending 2025-06-30)
Equity multiplier (leverage): 2.1320766888628397
ROE archetype: Standard Business
DuPont ROE decomposition for CYCN (annual period ending 2022-12-31)
ROE: -421.7183314198239%
Net margin: -14841.077441077443%
Asset turnover: 0.016427899773217545
Equity multiplier (leverage): 1.729716800612323
EBIT margin: -6242.424242424242%
ROE archetype: Low Return
DuPont ROE decomposition for CYCN (annual period ending 2023-12-31)
ROE: -48.41766329346826%
Asset turnover: 0
Equity multiplier (leverage): 1.4467801287948483
ROE archetype: Low Return
DuPont ROE decomposition for CYCN (annual period ending 2024-12-31)
ROE: -30.36051246399841%
Net margin: -152.85%
Asset turnover: 0.1742995337487472
Equity multiplier (leverage): 1.1395868507299634
EBIT margin: -181.4%
ROE archetype: Low Return
DuPont ROE decomposition for CYCN (annual period ending 2025-12-31)
ROE: -39.3420685809869%
Net margin: -1545.4136760962745%
Asset turnover: 0.023342371165644173
Equity multiplier (leverage): 1.0906049623640925
EBIT margin: -2178.3849805064547%
ROE archetype: Low Return
DuPont ROE decomposition for CYCU (annual period ending 2022-12-31)
ROE: -30.664433644859812%
Net margin: -9.264954371389003%
Asset turnover: 1.0039228412338475
Equity multiplier (leverage): 3.2967903302180686
EBIT margin: -1.003425835510499%
ROE archetype: Low Return
DuPont ROE decomposition for CYCU (annual period ending 2023-12-31)
ROE: -40.870531068037614%
Net margin: -10.837159993318934%
Asset turnover: 1.036692436992078
Equity multiplier (leverage): 3.637850652170354
EBIT margin: 1.6868604203117608%
Interest burden factor: -6.412853733483247
ROE archetype: Low Return
DuPont ROE decomposition for CYCU (annual period ending 2024-12-31)
ROE: 23.131980294187528%
Net margin: 6.9189547187531035%
Asset turnover: 0.7667054920000083
Equity multiplier (leverage): 4.360574905245684
EBIT margin: 13.59544798873026%
Interest burden factor: 0.5089170084346221
Tax burden factor: 1
ROE archetype: Leverage-Driven Returns
DuPont ROE decomposition for CYCU (annual period ending 2025-12-31)
ROE: -218.83784720859248%
Net margin: -156.3780891677994%
Asset turnover: 0.5128729834533264
Equity multiplier (leverage): 2.728580112206408
EBIT margin: -76.28529990160337%
ROE archetype: Low Return
DuPont ROE decomposition for CYD (annual period ending 2022-12-31)
ROE: 2.8361570330333663%
Net margin: 2.0938720085715876%
Asset turnover: 0.664136667357706
Equity multiplier (leverage): 2.0394951814371263
EBIT margin: 2.3383975532848478%
Interest burden factor: 1.0529957850931015
Tax burden factor: 0.8503645566798235
ROE archetype: Low Return
DuPont ROE decomposition for CYD (annual period ending 2023-12-31)
ROE: 3.5483358175811186%
Net margin: 2.3431664764989306%
Asset turnover: 0.7286315159245703
Equity multiplier (leverage): 2.078325746405494
EBIT margin: 2.0562053853663143%
Interest burden factor: 1.5397418276874983
Tax burden factor: 0.7400971730211847
ROE archetype: Low Return
DuPont ROE decomposition for CYD (annual period ending 2024-12-31)
ROE: 3.958614265237106%
Net margin: 2.5700476779692245%
Asset turnover: 0.7141226143469785
Equity multiplier (leverage): 2.156896069038975
EBIT margin: 2.453629287783386%
Interest burden factor: 1.3217968462107028
Tax burden factor: 0.7924420665871661
ROE archetype: Low Return
DuPont ROE decomposition for CYD (annual period ending 2025-12-31)
ROE: 6.623991439535837%
Net margin: 3.2864670065070754%
Asset turnover: 0.8590627560894388
Equity multiplier (leverage): 2.3462030491173063
EBIT margin: 3.9696458145829907%
Interest burden factor: 1.1646582940494492
Tax burden factor: 0.71085167907257
ROE archetype: Standard Business
DuPont ROE decomposition for CYM.V (quarterly period ending 2024-10-31)
Net margin: -285.73114482361%
Asset turnover: 0.09540628146073499
EBIT margin: -239.5973718664793%
ROE archetype: Standard Business
DuPont ROE decomposition for CYM.V (quarterly period ending 2025-01-31)
Net margin: -54.03184883516875%
Asset turnover: 0.3571129105652795
EBIT margin: -27.677763302693602%
ROE archetype: Standard Business
DuPont ROE decomposition for CYM.V (quarterly period ending 2025-04-30)
Net margin: -545.8356975130284%
Asset turnover: 0.08390045134507765
EBIT margin: -468.14729785172455%
ROE archetype: Standard Business